IRVINE, Calif.—Cyvex Nutrition is hosting a sponsored VendorWorks presentation at SupplySide West in Las Vegas; the session is set for Oct. 22, 2008, from 1 p.m. to 1:50 p.m. “Chirositol™: A Breakthrough Ingredient for use in Blood Sugar and Lipid Management” will be led by Joseph Larner, M.D., Ph.D., who will discuss how the administration of D-chiro-inositol (DCI) to diabetic humans and animals decreases elevated blood glucose and lipid levels. DCI also acts as an antioxidant, reducing reactive oxygen species, improving blood vessel health and maintaining nitric oxide signaling. DCI, when administered in combination with manganese chloride, was found to more effectively reduce elevated plasma glucose in diabetic rats.
“Our VendorWorks presentation is significant in that Dr. Larner is the discoverer of D-chiro-inositol in relation to insulin resistance and will be reviewing the science behind this unique nutraceutical ingredient,” said Matt Phillips, president, Cyvex. Chirositol is manufactured exclusively for Cyvex by Amicogen of South Korea.
